Amneal Pharmaceuticals, Inc. · NASDAQ:AMRX
The Vanguard Group reported a 5.02% stake in Amneal Pharmaceuticals, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed Apr 30, 2025
The Vanguard Group reported a 5.02% stake in Amneal Pharmaceuticals, Inc., 15,762,727 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G).
- Stake
- 5.02%
- Shares
- 15,762,727
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.02% | 15,762,727 |
Source
Related
- Amneal Pharmaceuticals, Inc.
- The Vanguard Group
- Amneal Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Buchi J Kevin · Sep 21, 2026
- Form 4 · Buchi J Kevin · Sep 14, 2026
- Form 4 · Boyer Andrew S · Sep 2, 2026
- Form 4 · Boyer Andrew S · Aug 25, 2026
- Form 4 · Kiely John · Aug 14, 2026